Please use this identifier to cite or link to this item: https://doi.org/10.3390/BIOMEDICINES8080264
Title: PTEN, a barrier for proliferation and metastasis of gastric cancer cells: From molecular pathways to targeting and regulation
Authors: Ashrafizadeh, M.
Najafi, M.
Ang, H.L.
Moghadam, E.R.
Mahabady, M.K.
Zabolian, A.
Jafaripour, L.
Bejandi, A.K.
Hushmandi, K.
Saleki, H.
Zarrabi, A.
Kumar, A.P. 
Keywords: Gastric cancer
Growth
Metastasis
Phosphatase and tensin homolog (PTEN)
PI3K/Akt
Issue Date: 3-Aug-2020
Publisher: MDPI AG
Citation: Ashrafizadeh, M., Najafi, M., Ang, H.L., Moghadam, E.R., Mahabady, M.K., Zabolian, A., Jafaripour, L., Bejandi, A.K., Hushmandi, K., Saleki, H., Zarrabi, A., Kumar, A.P. (2020-08-03). PTEN, a barrier for proliferation and metastasis of gastric cancer cells: From molecular pathways to targeting and regulation. Biomedicines 8 (8) : 264. ScholarBank@NUS Repository. https://doi.org/10.3390/BIOMEDICINES8080264
Rights: Attribution 4.0 International
Abstract: Cancer is one of the life-threatening disorders that, in spite of excellent advances in medicine and technology, there is no effective cure for. Surgery, chemotherapy, and radiotherapy are extensively applied in cancer therapy, but their efficacy in eradication of cancer cells, suppressing metastasis, and improving overall survival of patients is low. This is due to uncontrolled proliferation of cancer cells and their high migratory ability. Finding molecular pathways involved in malignant behavior of cancer cells can pave the road to effective cancer therapy. In the present review, we focus on phosphatase and tensin homolog (PTEN) signaling as a tumor-suppressor molecular pathway in gastric cancer (GC). PTEN inhibits the PI3K/Akt pathway from interfering with the migration and growth of GC cells. Its activation leads to better survival of patients with GC. Different upstream mediators of PTEN in GC have been identified that can regulate PTEN in suppressing growth and invasion of GC cells, such as microRNAs, long non-coding RNAs, and circular RNAs. It seems that antitumor agents enhance the expression of PTEN in overcoming GC. This review focuses on aforementioned topics to provide a new insight into involvement of PTEN and its downstream and upstream mediators in GC. This will direct further studies for evaluation of novel signaling networks and their targeting for suppressing GC progression. © 2020 by the authors.
Source Title: Biomedicines
URI: https://scholarbank.nus.edu.sg/handle/10635/198658
ISSN: 22279059
DOI: 10.3390/BIOMEDICINES8080264
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_BIOMEDICINES8080264.pdf1.35 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons